fda remove semaglutide from shortage list resolved feb 21 2025 Novo's Wegovy and Ozempic removed US list, compounders on notice FDA Declares Shortage of Novo – Federal judge upholds FDA's removal

Form(s): tablet ( Foundayo orforglipron ): a once-daily oral tablet approved for weight management in adults with obesity or overweight

it is not an FDA-approved finished drug product, which is the key regulatory distinction from branded semaglutide

This is like being somewhere in the wintertime and freezing to death, and all of the firewood is stacked outside, but you can't get it into the fireplace

Results While GLP-1 and GIP agonists demonstrate significant metabolic benefits, their long-term use is often limited by gastrointestinal side effects and psychological impacts

Leg cramps are not listed as a recognized adverse effect in the official FDA prescribing information for semaglutide products